Cargando…
“Associated” or “Secondary” IgA nephropathy? An outcome analysis
BACKGROUND: Whether differences in outcome between primary (pIgAN) and secondary IgA nephropathy (sIgAN) exist is uncertain. METHODS: We conducted a retrospective, observational study that included all histologically diagnosed IgAN patients between 2010–2017 (N = 306), 248 with pIgAN and 58 with sIg...
Autores principales: | Obrișcă, Bogdan, Ștefan, Gabriel, Gherghiceanu, Mihaela, Mandache, Eugen, Ismail, Gener, Stancu, Simona, Boitan, Bianca, Ion, Oana, Mircescu, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688810/ https://www.ncbi.nlm.nih.gov/pubmed/31398224 http://dx.doi.org/10.1371/journal.pone.0221014 |
Ejemplares similares
-
Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy?
por: Obrișcă, Bogdan, et al.
Publicado: (2019) -
Histologic predictors of renal outcome in diabetic nephropathy: Beyond renal pathology society classification
por: Stefan, Gabriel, et al.
Publicado: (2019) -
Hydroxychloroquine in IgA nephropathy: a systematic review
por: Stefan, Gabriel, et al.
Publicado: (2021) -
Kidney Involvement in Hypocomplementemic Urticarial Vasculitis Syndrome—A Case-Based Review
por: Ion, Oana, et al.
Publicado: (2020) -
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy
por: Obrisca, Bogdan, et al.
Publicado: (2015)